Conferences on Antiviral Research present a wealth of new information on novel drug development and the ... respiratory and emerging viruses, hepatitis viruses, clinical update on antiviral ...
Paxlovid is likely to lose some efficacy due to drug resistance. Researchers working to stay ahead of such emerging threats have now identified a wholly new way to treat SARS-CoV-2 infections ...
2don MSN
Researchers have applied AI to every step of the drug development process. But this might not be enough to design safe and effective drugs.
To combat this, new ... the development of anti-HIV drugs. For example, in the early 1990s, 'transition-state' mimicry also inspired the design of influenza virus neuraminidase (also known as ...
Paxlovid is likely to lose some efficacy due to drug resistance. Researchers working to stay ahead of such emerging threats have now identified a wholly new way to treat SARS-CoV-2 infections ...
Between 2007 and 2016, 77% of Food and Drug Administration-approved new drugs were small molecule treatments, which typically come in the form of pills or tablets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback